المؤلفون: Abdelbaky SB; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Giacopelli B; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rabe KG; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN., Yamaguchi K; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wu YZ; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Yan H; Division of Computational Biology, Mayo Clinic, Rochester, MN., Shanafelt TD; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN., Ding W; Division of Hematology, Mayo Clinic, Rochester, MN., Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, MN., Brown S; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Cerhan JR; Division of Epidemiology, Mayo Clinic, Rochester, MN., Vachon CM; Division of Epidemiology, Mayo Clinic, Rochester, MN., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN.; Department of Immunology, Mayo Clinic, Rochester, MN., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Parker AS; College of Medicine, University of Florida, Jacksonville, FL., Braggio E; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Slager SL; Division of Computational Biology, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Oakes CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH.

المصدر: Blood [Blood] 2024 Apr 25; Vol. 143 (17), pp. 1752-1757.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocytosis*/genetics , Lymphocytosis*/diagnosis , Lymphocytosis*/immunology , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/immunology , Leukemia, Lymphocytic, Chronic, B-Cell*/mortality , Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis , B-Lymphocytes*/immunology , B-Lymphocytes*/pathology, Humans ; Female ; Male ; Aged ; Middle Aged ; Prognosis ; Epigenesis, Genetic ; Aged, 80 and over ; Adult

المؤلفون: Sakemura RL; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Manriquez Roman C; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN., Horvei P; T Cell Engineering, Mayo Clinic, Rochester, MN.; Pediatric Bone Marrow Transplant and Cellular Therapy, UPMC Children's Hospital of Pittsburgh, PA., Siegler EL; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Girsch JH; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN., Sirpilla OL; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN., Stewart CM; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN., Yun K; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN., Can I; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN., Ogbodo EJ; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Adada MM; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Bezerra ED; T Cell Engineering, Mayo Clinic, Rochester, MN., Kankeu Fonkoua LA; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Hefazi M; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Ruff MW; T Cell Engineering, Mayo Clinic, Rochester, MN.; Department of Neurology, Mayo Clinic, Rochester, MN., Kimball BL; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Mai LK; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Huynh TN; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Nevala WK; Department of Immunology, Mayo Clinic, Rochester, MN., Ilieva K; Morphosys AG, Planegg, Germany., Augsberger C; Morphosys AG, Planegg, Germany., Patra-Kneuer M; Morphosys AG, Planegg, Germany., Schanzer J; Morphosys AG, Planegg, Germany., Endell J; Morphosys AG, Planegg, Germany., Heitmüller C; Morphosys AG, Planegg, Germany., Steidl S; Morphosys AG, Planegg, Germany., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN., Ding W; Division of Hematology, Mayo Clinic, Rochester, MN., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN., Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, MN.; Division of Hematology, Mayo Clinic, Rochester, MN.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN.; Department of Immunology, Mayo Clinic, Rochester, MN.

المصدر: Blood [Blood] 2024 Jan 18; Vol. 143 (3), pp. 258-271.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy* , Antibodies, Monoclonal, Humanized*, Therapeutic Index ; Antigens, CD19 ; Immunotherapy, Adoptive/methods

المؤلفون: Papazoglou D; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Wang XV; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA., Shanafelt TD; School of Medicine, Stanford University, Stanford, CA., Lesnick CE; Department of Immunology, Mayo Clinic, Rochester, MN., Ioannou N; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., De Rossi G; Institute of Ophthalmology, University College London, London, United Kingdom., Herter S; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland., Bacac M; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland., Klein C; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland., Tallman MS; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Kay NE; Department of Immunology, Mayo Clinic, Rochester, MN., Ramsay AG; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.

المصدر: Blood [Blood] 2024 Jan 04; Vol. 143 (1), pp. 57-63.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*, Humans ; Rituximab ; Monitoring, Immunologic ; Antineoplastic Combined Chemotherapy Protocols ; Cyclophosphamide ; Immunotherapy ; CD8-Positive T-Lymphocytes

المؤلفون: Slager SL; Division of Hematology, Mayo Clinic, Rochester, MN.; Division of Computational Biology, Mayo Clinic, Rochester, MN., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN., Achenbach SJ; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN., Norman AD; Division of Epidemiology, Mayo Clinic, Rochester, MN., Rabe KG; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN., Boddicker NJ; Division of Computational Biology, Mayo Clinic, Rochester, MN., Olson JE; Division of Epidemiology, Mayo Clinic, Rochester, MN., Kleinstern G; Division of Computational Biology, Mayo Clinic, Rochester, MN.; School of Public Health, University of Haifa, Haifa, Israel., Lesnick CE; Division of Hematology, Mayo Clinic, Rochester, MN., Call TG; Division of Hematology, Mayo Clinic, Rochester, MN., Cerhan JR; Division of Epidemiology, Mayo Clinic, Rochester, MN., Vachon CM; Division of Epidemiology, Mayo Clinic, Rochester, MN., Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN., Braggio E; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Hanson CA; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Shanafelt TD; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.

المصدر: Blood [Blood] 2022 Oct 13; Vol. 140 (15), pp. 1702-1709.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/pathology , Leukemia, Lymphocytic, Chronic, B-Cell*/pathology , Lymphocytosis*/diagnosis , Neoplasms, Plasma Cell*/pathology , Precancerous Conditions*/pathology, Adult ; B-Lymphocytes/pathology ; Humans

المؤلفون: Shanafelt TD; Stanford University, Stanford, CA., Wang XV; Dana Farber Cancer Institute, Boston, MA., Hanson CA; Mayo Clinic, Rochester, MN., Paietta EM; Montefiore Medical Center, Bronx, NY., O'Brien S; University of California Irvine Medical Center, Irvine, CA., Barrientos J; Northwell Health/Center for Advanced Medicine, New Hyde Park, NY., Jelinek DF; Mayo Clinic, Rochester, MN., Braggio E; Mayo Clinic, Rochester, MN., Leis JF; Mayo Clinic, Rochester, MN., Zhang CC; Kaiser Permanente NCORP/The Permanente Medical Group, Fresno, CA., Coutre SE; Stanford University, Stanford, CA., Barr PM; Rochester University, Rochester, NY., Cashen AF; Washington University School of Medicine, St. Louis, MO., Mato AR; Memorial Sloan-Kettering Cancer Center, New York, NY., Singh AK; Minnesota Oncology, Burnsville, MN., Mullane MP; Aurora Cancer Care, Milwaukee West, Milwaukee, WI., Little RF; National Cancer Institute, Bethesda, MD; and., Erba H; Duke University, Durham, NC., Stone RM; Dana Farber Cancer Institute, Boston, MA., Litzow M; Mayo Clinic, Rochester, MN., Tallman M; Memorial Sloan-Kettering Cancer Center, New York, NY., Kay NE; Mayo Clinic, Rochester, MN.

المصدر: Blood [Blood] 2022 Jul 14; Vol. 140 (2), pp. 112-120.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/genetics, Adenine/analogs & derivatives ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/adverse effects ; Disease Progression ; Humans ; Immunoglobulin Variable Region ; Piperidines ; Rituximab/therapeutic use ; Treatment Outcome

المؤلفون: Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: kay.neil@mayo.edu., Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, MN, United States of America., Van Dyke DL; Department of Laboratory Medicine & Pathology, Division of Mayo Clinic Hematopathology, United States of America., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, United States of America.

المصدر: Blood reviews [Blood Rev] 2022 Jul; Vol. 54, pp. 100930. Date of Electronic Publication: 2022 Jan 26.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/etiology , Lymphoma, B-Cell*/drug therapy, Humans ; Immunotherapy ; Prognosis

المؤلفون: Sakemura R; T Cell Engineering.; Division of Hematology., Hefazi M; T Cell Engineering.; Division of Hematology., Siegler EL; T Cell Engineering.; Division of Hematology., Cox MJ; T Cell Engineering.; Division of Hematology., Larson DP; Division of Hematopathology., Hansen MJ; Department of Immunology., Manriquez Roman C; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Medicine., Schick KJ; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences.; Department of Molecular Pharmacology and Experimental Therapeutics, and., Can I; T Cell Engineering.; Division of Hematology.; Mayo Clinic Graduate School of Biomedical Sciences., Tapper EE; T Cell Engineering.; Division of Hematology., Horvei P; T Cell Engineering., Adada MM; T Cell Engineering.; Division of Hematology., Bezerra ED; T Cell Engineering.; Division of Hematology., Kankeu Fonkoua LA; T Cell Engineering.; Division of Hematology., Ruff MW; T Cell Engineering.; Department of Neurology, Mayo Clinic, Rochester, MN; and., Nevala WK; Department of Immunology., Walters DK; Department of Immunology., Parikh SA; Division of Hematology., Lin Y; Division of Hematology., Jelinek DF; Department of Immunology., Kay NE; Division of Hematology., Bergsagel PL; Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ., Kenderian SS; T Cell Engineering.; Division of Hematology.; Department of Immunology.; Department of Molecular Medicine.

المصدر: Blood [Blood] 2022 Jun 30; Vol. 139 (26), pp. 3708-3721.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Cancer-Associated Fibroblasts*/pathology , Multiple Myeloma*/pathology, Bone Marrow ; Cell- and Tissue-Based Therapy ; Fibroblasts ; Humans ; Immunotherapy, Adoptive/methods ; Tumor Microenvironment

المؤلفون: Purroy N; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA., Tong YE; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA.; Program in Health Sciences and Technology, Harvard Medical School-Massachusetts Institute of Technology, Boston, MA., Lemvigh CK; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Cieri N; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA., Li S; Broad Institute, Cambridge, MA.; Translational Immunogenomics Laboratory, Dana Farber Cancer Institute, Boston, MA., Parry EM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA., Zhang W; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA., Rassenti LZ; Moores Cancer Center, University of California San Diego, La Jolla, CA., Kipps TJ; Moores Cancer Center, University of California San Diego, La Jolla, CA., Slager SL; Department of Health Sciences Research and., Kay NE; Department of Health Sciences Research and.; Department of Medicine, Mayo Clinic, Rochester, MN., Lesnick C; Department of Medicine, Mayo Clinic, Rochester, MN., Shanafelt TD; Department of Medicine, Stanford University, Stanford, CA., Ghia P; Division of Experimental Oncology, Department of Onco-Hematology, Università Vita-Salute San Raffaele-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan Italy., Scarfò L; Division of Experimental Oncology, Department of Onco-Hematology, Università Vita-Salute San Raffaele-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan Italy., Livak KJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Translational Immunogenomics Laboratory, Dana Farber Cancer Institute, Boston, MA., Kharchenko PV; Department of Biomedical Informatics, Harvard Medical School, Boston, MA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Olsen LR; Program in Health Sciences and Technology, Harvard Medical School-Massachusetts Institute of Technology, Boston, MA.; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Fan J; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD., Gohil SH; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA.; Department of Academic Haematology, University College London, United Kingdom; and., Wu CJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute, Cambridge, MA.; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

المصدر: Blood [Blood] 2022 Apr 07; Vol. 139 (14), pp. 2252-2256.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy, Adenine/analogs & derivatives ; Humans ; Piperidines ; Protein Kinase Inhibitors ; Single-Cell Analysis

المؤلفون: Wang XV; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA., Hanson CA; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN., Tschumper RC; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN., Lesnick CE; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN., Braggio E; Department of Hematology/Oncology, Mayo Clinic in Arizona, Scottsdale, AZ., Paietta EM; Department of Oncology, Montefiore Medical Center, Brooklyn, NY., O'Brien S; Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Irvine, CA., Barrientos JC; Northwell Health Center for Advanced Medicine, New Hyde Park, NY., Leis JF; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic in Arizona, Phoenix, AZ., Zhang CC; Department of Hematology/Oncology, Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)/The Permanente Medical Group, Fresno, CA., Coutre SE; Department of Medicine, Stanford University, Stanford, CA., Barr PM; Department of Medicine, Rochester University, Rochester, NY., Cashen AF; Department of Medicine, Washington University School of Medicine, St Louis, MO., Mato AR; CLL Program, Memorial Sloan-Kettering Cancer Center, New York, NY., Singh AK; Fairview Ridges Hospital, Burnsville, MN., Mullane MP; Aurora Cancer Care-Milwaukee West, Milwaukee, WI., Erba H; Department of Medicine, Duke University Medical Center, Durham, NC., Stone R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and., Litzow MR; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN., Tallman MS; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY., Shanafelt TD; Department of Medicine, Stanford University, Stanford, CA., Kay NE; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN.

المصدر: Blood [Blood] 2021 Dec 30; Vol. 138 (26), pp. 2810-2827.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy , Neoplasm, Residual/*diagnosis , Piperidines/*therapeutic use , Protein Kinase Inhibitors/*therapeutic use, Adenine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Rituximab/therapeutic use ; Treatment Outcome ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use

المؤلفون: Parikh SA; Division of Hematology, Department of Medicine and., Rabe KG; Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN., Kay NE; Division of Hematology, Department of Medicine and., Call TG; Division of Hematology, Department of Medicine and., Ding W; Division of Hematology, Department of Medicine and., Leis JF; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Kenderian SS; Division of Hematology, Department of Medicine and., Muchtar E; Division of Hematology, Department of Medicine and., Wang Y; Division of Hematology, Department of Medicine and., Koehler AB; Division of Hematology, Department of Medicine and., Schwager SM; Division of Hematology, Department of Medicine and., Lesnick CE; Division of Hematology, Department of Medicine and., Kleinstern G; Division of Hematology, Department of Medicine and.; School of Public Health, University of Haifa, Haifa, Israel., Van Dyke D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and., Hanson CA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and., Braggio E; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Slager SL; Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN., Shanafelt TD; Division of Hematology, Stanford University School of Medicine, Palo Alto, CA.

المصدر: Blood [Blood] 2021 Jul 15; Vol. 138 (2), pp. 149-159.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocytes/*immunology , Leukemia, Lymphocytic, Chronic, B-Cell/*diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell/*immunology , Lymphocytosis/*immunology, Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Survival Analysis